Signature Pharmaceuticals Limited

Signature Pharmaceuticals Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH1995PLC085225 Incorporated 03 February 1995 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Public Limited Company pharma
Revenue · FY 2025
₹16.97 Lakh
▲ 17% YoY
Net profit · FY 2025
₹82,646
Net margin 4.9%
EBITDA · FY 2025
₹3.52 Lakh
EBITDA margin 20.7%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹64.85 Lakh
Issued & subscribed
Company age
31 yrs
Est. 1995
Directors on board
3
As per MCA filings
GST registrations
1
None active

About Signature Pharmaceuticals Limited

Data last updated:

Signature Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 February 1995 and has been in existence for over 31 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1995PLC085225. The company has 1 GST registration on record, which is no longer active.

The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹64.85 Lakh. It is led by directors including Krishnakumar Radharaman Agarwal and Sanjiv Surajbhan Garg.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 310 T.V. Industrial Estate S.K. Ahire Marg Worli, Mumbai, Maharashtra, India – 400030.

As per the financials filed for FY 2025, the company reported a revenue of ₹16.97 Lakh, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹82,646 (net margin 4.9%) and EBITDA of ₹3.52 Lakh (EBITDA margin 20.7%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 8% over five years.

Its group structure includes 1 subsidiary.

The company is associated with 1 brand: HAB Pharma. Court records list 19 cases involving the company, including 13 filed by the company and 6 filed against it; 10 cases are pending.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website signature-pharmaceuticals.com.

Company details

CIN U24230MH1995PLC085225
Registration Number 085225
Incorporation Date 03 February 1995
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Signature Pharmaceuticals Limited's registered office is in Mumbai, Maharashtra. Its website is signature-pharmaceuticals.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    310 T.V. Industrial Estate S.K. Ahire Marg Worli, Mumbai, Maharashtra, India – 400030
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Signature Pharmaceuticals Limited, buy the company report.

Comprehensive company report
Signature Pharmaceuticals Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Signature Pharmaceuticals operates one associated brand: HAB Pharma. Each brand links to its own profile.

BrandDescriptionWebsite
Specializes in manufacturing and selling pharmaceutical formulations, including tablets, capsules, ointments, and eye drops.habpharma.com

Financials of Signature Pharmaceuticals Limited

FY 2025 filings available

Signature Pharmaceuticals Limited reported revenue of ₹16.97 Lakh (up 17% YoY) for FY 2025.

Revenue · FY 2025
₹16.97 Lakh ▲ 17%
Net profit · FY 2025
₹82,646 margin 4.9%
EBITDA · FY 2025
₹3.52 Lakh margin 20.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 21%
5 years · compounded
▲ 8%
EBITDA CAGR growth
1 year
▼ 34%
3 years · compounded
▲ 79%
5 years · compounded
▼ 13%

Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 17% growth in the latest year. EBITDA fell 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹3.52 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹82,646
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin20.7%
Net Profit Margin4.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Signature Pharmaceuticals Limited, buy the company report.

Board of directors of Signature Pharmaceuticals Limited

Signature Pharmaceuticals has 3 directors on record. No former directors are listed.

Auditor

Signature Pharmaceuticals Limited is audited by Bhuwania & Agrawal Associates for the financial year 2022.

Auditor firmFinancial yearFirm registration number
Bhuwania & Agrawal AssociatesFY 2022101483W

Shareholding

The shareholding of Signature Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Signature Pharmaceuticals Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Signature Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Group structure & subsidiaries

Signature Pharmaceuticals has 1 subsidiary company. This group structure data is as of FY 2022. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Asim Software Solutions Private LimitedU31909MH1988PTC046678

To see the full group structure of Signature Pharmaceuticals Limited, buy the company report.

GST

Signature Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1

To see the full GST registrations and return filing status of Signature Pharmaceuticals Limited, buy the company report.

Recent activity

Signature Pharmaceuticals Limited has 3 board changes on record since 1995: 3 appointments. The latest: Krishnakumar Radharaman Agarwal was appointed as Director on 03 Feb 1995.

AGM
Signature Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Signature Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Krishnakumar Radharaman Agarwal was appointed as Director.
Appointed
Sanjiv Surajbhan Garg was appointed as Director.
Appointed
Vinita Krishnakumar Agarwal was appointed as Director.
Incorporation
03 Feb 1995
Signature Pharmaceuticals Limited was registered on 03 Feb 1995 with Roc Mumbai & aged 31 years 9 months as per MCA records.

Frequently asked questions

Signature Pharmaceuticals is an active public limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 February 1995 (31+ years old) and is registered under CIN U24230MH1995PLC085225.

Signature Pharmaceuticals has 3 current directors:

The latest financial statements of Signature Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

No. Signature Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.

The CIN (Corporate Identification Number) of Signature Pharmaceuticals is U24230MH1995PLC085225. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Signature Pharmaceuticals has 19 court cases on record: 13 filed by the company and 6 filed against it. 10 are pending.

Signature Pharmaceuticals was incorporated on 03 February 1995, making it 31+ years old. It is registered with the Registrar of Companies, Mumbai.

Krishnakumar Radharaman Agarwal was appointed as Director on 03 Feb 1995. Sanjiv Surajbhan Garg was appointed as Director on 03 Feb 1995. Vinita Krishnakumar Agarwal was appointed as Director on 03 Feb 1995.

Signature Pharmaceuticals can be reached through the website signature-pharmaceuticals.com. Its registered office is in Mumbai, Maharashtra, India.

The registered office of Signature Pharmaceuticals is at 310 T.V. Industrial Estate S.K. Ahire Marg Worli, Mumbai, Maharashtra, India – 400030.